Steve E. Krognes, Director at Guardant Health, holds 7.91K shares in Guardant Health (Ticker: GH), holds ― shares in Pliant Therapeutics (Ticker: PLRX), holds 820.00K shares in Denali Therapeutics (Ticker: DNLI). Most recently, Steve E. Krognes Sold ― shares of Guardant Health on Sep 17, 2026 for an estimated value of $1.17M.
What is the percentage of profitable transactions made by Steve E. Krognes?
The percentage of profitable transactions made by Steve E. Krognes is 72%.
What is the average return per transaction made by Steve E. Krognes?
The average return per transaction made by Steve E. Krognes is 3.80%.
What stocks does Steve E. Krognes hold?
Steve E. Krognes holds: GH, PLRX, DNLI, CRVS, GRTSQ stocks.
What was Steve E. Krognes’s latest transaction?
Steve E. Krognes latest transaction was an Informative Sell of $1.17M.
What was Steve E. Krognes's most profitable transaction?
Steve E. Krognes’s most profitable transaction was an Informative Sell of DNLI stock on February 16, 2021. The return on the trade was 44.30%.
What is Steve E. Krognes's role in Guardant Health?
Steve E. Krognes's role in Guardant Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.